New inhibitors of dihydropteridine reductase (human brain). 1993

D Randles, and H Taguchi, and W L Armarego
Therapeutic Goods Administration, Dept. of Health, Housing and Community Services, Woden, ACT, Australia.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011622 Pterins Compounds based on 2-amino-4-hydroxypteridine. Pterin
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004093 Dihydropteridine Reductase An enzyme that catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine in the presence of NADP+. Defects in the enzyme are a cause of PHENYLKETONURIA II. Formerly listed as EC 1.6.99.7. 6,7-Dihydropteridine Reductase,6,7 Dihydropteridine Reductase,Reductase, 6,7-Dihydropteridine,Reductase, Dihydropteridine
D005492 Folic Acid A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. Pteroylglutamic Acid,Vitamin M,Folacin,Folate,Folic Acid, (D)-Isomer,Folic Acid, (DL)-Isomer,Folic Acid, Calcium Salt (1:1),Folic Acid, Monopotassium Salt,Folic Acid, Monosodium Salt,Folic Acid, Potassium Salt,Folic Acid, Sodium Salt,Folvite,Vitamin B9,B9, Vitamin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

D Randles, and H Taguchi, and W L Armarego
January 1987, Methods in enzymology,
D Randles, and H Taguchi, and W L Armarego
April 1987, European journal of biochemistry,
D Randles, and H Taguchi, and W L Armarego
July 1982, The Journal of biological chemistry,
D Randles, and H Taguchi, and W L Armarego
May 1987, Proceedings of the National Academy of Sciences of the United States of America,
D Randles, and H Taguchi, and W L Armarego
January 1981, Journal of neuroscience research,
D Randles, and H Taguchi, and W L Armarego
January 1979, Blood,
D Randles, and H Taguchi, and W L Armarego
January 1989, Journal of enzyme inhibition,
D Randles, and H Taguchi, and W L Armarego
January 1993, Advances in experimental medicine and biology,
D Randles, and H Taguchi, and W L Armarego
April 1988, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!